small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 42 results

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Practice Area

Technology Antitrust

As society and business become even more digitalized, technology and intellectual property (IP) have become key focal points for businesses. Our Technology Antitrust Group combines the cross-practice and cross-office experience of our lawyers to assist clients in successfully navigating the dynamic convergence of technology, antitrust, and IP law. We understand the challenges presented by the ever-changing digital landscape and are committed to providing our clients with tailored solutions to address their specific needs....Read more

Practice Area

Antitrust/Competition

Experience 112 results

Experience

|

March 18, 2026

Winston & Strawn LLP Advises Maxim Group LLC on $100 Million IPO of BHAV Acquisition Corp

Winston & Strawn LLP represented the underwriter, Maxim Group LLC, in connection with the $100 million initial public offering of BHAV Acquisition Corp. The offering consisted of 10,000,000 units priced at $10.00 per unit, with each unit comprising one Class A ordinary share and one right. Each right entitles the holder to receive one-fourth (1/4) of one Class A ordinary share upon the consummation of the Company’s initial business combination....Read more

Experience

|

March 16, 2026

Winston & Strawn Advises D. Boral Capital on $120 Million IPO of Pono Capital Four, Inc.

Winston & Strawn LLP served as counsel to D. Boral Capital LLC in connection with the $120 million initial public offering of Pono Capital Four, Inc.. The offering was led by D. Boral Capital LLC as sole book-running manager and consisted of 12,000,000 units priced at $10.00 per unit....Read more

Experience

|

March 6, 2026

Transition Evergreen & Zencap Agreement: Winston Advises Transition Evergreen on Its Restructuring

Transition Evergreen, a company listed on Euronext Paris and dedicated to ecological transition and carbon-footprint reduction, has completed the first phase of its financial restructuring by carrying out, on February 26 and 27, 2026, the operations set out in a settlement agreement concluded with its main creditor, a private debt fund managed by Zencap Asset Management (“Zencap”)....Read more
View All Experience

Insights & News 733 results

In the Media

|

April 16, 2026

|

4 Min Read

Winston Secures Transformative Antitrust Verdict for States in Live Nation and Ticketmaster Trial

A Winston & Strawn team, led by Jeffrey Kessler, secured an antitrust verdict on behalf of more than 30 states and the District of Columbia, with a Manhattan federal jury finding Live Nation Entertainment and Ticketmaster liable for violating federal and state antitrust laws in a decision that has the potential to transform the concert, music, and ticketing industry. The jury concluded that Ticketmaster unlawfully maintained a monopoly in the primary ticketing market for major concert venues and that Live Nation unlawfully monopolized the large amphitheater market, compelling artists to use its promotion services to access its venues. Jurors further found that this conduct resulted in higher ticket fees, leading to an approximate $1.72 overcharge per ticket for consumers....Read more

Winston’s Environmental Law Update

|

April 15, 2026

|

5 Min Read

EPA Issues New Emergency E15 Waiver and Renewable Fuel Standard Rule for 2026-2027 Amid Rising Fuel Costs Associated with Iran War

In October 2025, we covered the evolving legal landscape surrounding E15 gasoline—a fuel blend containing 15% ethanol—including the EPA's history of issuing short-term emergency waivers to allow summer sales, California's decision to authorize E15 statewide, and the introduction of the bipartisan Nationwide Consumer and Fuel Retailer Choice Act of 2025 in Congress.

Non-Fungible Insights: Blockchain Decrypted

|

March 26, 2026

|

6 Min Read

FCA Handbook Application for Regulated Cryptoasset Activities – Key Takeaways from CP26/4

The close of 2025 highlighted the continuing momentum for the digital asset industry, with regulatory developments accelerating rather than slowing.

View All Insights & News

Other Results 29 results

Site Content

What Is the Price Range in an IPO?

The price range is a proposed price per share range for the IPO within which investors can bid for shares and which is often printed on the cover page of a preliminary prospectus. The price range has a minimum price, known as the floor price, and a maximum price, known as the cap price....Read more

Site Content

What Is the BPCIA?

Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) to provide an abbreviated pathway for biosimilars to gain FDA approval through submission of an abbreviated Biologics License Application (aBLA)....Read more

Site Content

What Is Dilution?

Dilution refers to the reduction in an existing shareholder’s ownership percentage of a company when the company issues additional shares. Dilution in an IPO results from a disparity between the public offering price in an IPO and the effective cash cost to persons who acquired shares prior to the IPO. Dilution is disclosed in the registration statement in a dilution table....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising